Immune system dysregulation following short- vs long-duration spaceflight.
BACKGROUND
Immune system dysregulation has been demonstrated to occur during and immediately following spaceflight. If found to persist during lengthy flights, this phenomenon could be a serious health risk to crewmembers participating in lunar or Mars missions.


METHODS
A comprehensive postflight immune assessment was performed on 17 short-duration Space Shuttle crewmembers and 8 long-duration International Space Station (ISS) crewmembers. Testing consisted of peripheral leukocyte subset analysis, early T cell activation potential, and intracellular/secreted cytokine profiles.


RESULTS
For Shuttle crewmembers, the distribution of the peripheral leukocyte subsets was found to be altered postflight. Early T cell activation was elevated postflight; however, the percentage of T cell subsets capable of being stimulated to produce IL-2 and IFN gamma was decreased. The ratio of secreted IFN gamma:IL-10 following T cell stimulation declined after landing, indicating a Th2 shift. For the ISS crewmembers, some alterations in peripheral leukocyte distribution were also detected after landing. In contrast to Shuttle crewmembers, the ISS crewmembers demonstrated a statistically significant reduction in early T cell activation potential immediately postflight. The percentage of T cells capable of producing IL-2 was reduced, but IFN gamma percentages were unchanged. A reduction in the secreted IFN gamma:IL-10 ratio (Th2 shift) was also observed postflight in the ISS crewmembers.


CONCLUSIONS
These data indicate that consistent peripheral phenotype changes and altered cytokine production profiles occur following spaceflight of both short and long duration; however, functional immune dysregulation may vary related to mission duration. In addition, a detectable Th2 cytokine shift appears to be associated with spaceflight.
Crucian
Brian E
BE
NASA-Johnson Space Center, Houston, TX, USA. brian.crucian-1@nasa.gov
Stowe
Raymond P
RP
Pierson
Duane L
DL
Sams
Clarence F
CF
D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007107:Immune System / Q000276:immunology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D010865:Pilot Projects; D013026:Space Flight; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology; D018418:Th2 Cells / Q000166:cytology* / Q000276:immunology; D013997:Time Factors; D014893:Weightlessness / Q000009:adverse effects*